Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
PRINCETON, N.J., Nov. 19 (HSMN NewsFeed) -- Novo Nordisk Inc. announced today that it has signed an exclusive agreement with Sciele Pharma, Inc. to market Prandinreg; (repaglinide). Under the terms of the agreement, Sciele will exclusively market Prandi... Biopharmaceuticals, EndocrinologyNovo Nordisk, Sciele Pharma, Prandin, repaglinide, diabetes (Source: HSMN NewsFeed)

UN Commissioners Aim for Increased Access to Health Commodities - 22 May 2012
UNITED NATIONS, New Yorkmdash;Affordable, life-saving medicines and health supplies with the potential to save millions of lives are not reaching the children and women who most need them.To help change this, members of the United Nations Commission on Life-Saving Commodities for Women and Children will today review and finalize recommendations to help increase access, reduce costs, and increase demand for 13 products. (Source: UNFPA News)